Opportunity Information: Apply for PA 10 011
Apply for PA 10 011
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Behavioral and Integrative Treatment Development Program (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Oct 28, 2010 and posted on Oct 14, 2009.
- Applicants must submit their applications by Jan 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: County governments Special district governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities For profit organizations other than small businesses City or township governments State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Behavioral and Integrative Treatment Development Program (R03) (Funding Opportunity Number PA-10-011) is an NIH discretionary grant opportunity designed to support small, focused research projects in drug abuse and addiction treatment development, including related HIV prevention and chronic pain treatment work. The central aim is to give early career investigators, as well as established investigators who are pivoting into a new research direction, a practical funding pathway for discrete projects that can realistically be completed within a two-year period using limited resources. In other words, it is meant for tightly scoped studies that move an intervention or a research approach forward without requiring the budget, infrastructure, or timeline of a larger clinical trial or multi-site program.
Scientifically, the program targets behavioral, combined, sequential, or integrated interventions, including models that blend behavioral approaches with pharmacological components. The topics NIH highlights include drug abuse treatment interventions across a range of real-world settings, with explicit interest in interventions tailored for patients who have comorbidities (for example, co-occurring mental health conditions, infectious diseases, or other health complications that affect treatment response and engagement). A second major area is prevention of HIV acquisition or transmission among individuals who are in drug abuse treatment, recognizing that treatment settings can be key points for HIV risk reduction, testing, linkage, and prevention services. A third emphasis is on improving adherence, not only to drug abuse treatment itself, but also to HIV medications and addiction pharmacotherapies, reflecting the public health importance of sustained engagement and medication-taking behavior. Finally, the FOA includes interventions to treat chronic pain, which intersects with substance use due to issues such as opioid prescribing, misuse risk, and the need for non-addictive or integrative pain management strategies.
The FOA is flexible about the type of small project proposed, as long as it is well-defined and feasible within two years. Examples specifically called out include Stage I pilot or feasibility studies (often used to test acceptability, refine protocols, or generate preliminary effect size estimates), secondary analyses of existing datasets (useful for answering targeted questions quickly and efficiently), and small self-contained research projects that do not require extensive infrastructure. NIH also encourages projects focused on developing research assessments or methodology, which can include creating or validating measures relevant to treatment outcomes, adherence, or behavioral mechanisms. Another encouraged category is the development of new research technology, which could involve tools or platforms that improve measurement, intervention delivery, monitoring, or implementation in treatment settings.
From an administrative and funding standpoint, this opportunity uses the NIH Small Research Grant (R03) mechanism. The R03 mechanism is typically used for limited-scope projects and is consistent with the FOA's emphasis on short duration (up to two years) and modest resources. This announcement is described as running in parallel with other NIH announcements that share the same scientific scope but use different grant mechanisms: PA-10-012 for the R01 (a larger, full-scale research project grant) and PA-10-013 for the R34 (often used for clinical trial planning and pilot work that precedes larger trials). That parallel structure matters because it signals that applicants should choose the mechanism that fits the maturity and scale of their project, with PA-10-011 being the small-project on-ramp.
Awards under this FOA are contingent on the availability of funds and on NIH receiving a sufficient number of meritorious applications, meaning there is no guaranteed number of awards spelled out in the summary information provided. The CFDA number associated with the program is 93.279 (Drug Abuse and Addiction Research Programs), and the sponsoring agency is the National Institutes of Health. There is no cost sharing or matching requirement.
Eligibility is broad and spans many types of domestic and non-domestic organizations. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (including small businesses, and for-profit entities other than small businesses); Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized tribal governments); and other categories referenced in the full announcement. The eligibility list also explicitly includes institutions and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, U.S. territories or possessions, regional organizations, eligible federal agencies, and foreign (non-U.S.) organizations or other non-domestic entities. This breadth reflects NIH's interest in supporting research across varied settings and populations, including community and treatment-system partners that are often central to behavioral intervention development and testing.
Key dates in the source information show the opportunity was posted October 14, 2009, with a creation date listed as October 28, 2010. The original and current closing date are both January 7, 2013, and the archive date is February 7, 2013, indicating that this specific FOA is historical rather than currently open. The full announcement link provided is http://grants.nih.gov/grants/guide/pa-files/PA-10-011.html, and the contact listed for access or linking issues is the NIH Office of Extramural Research (OER) Webmaster (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is the Behavioral and Integrative Treatment Development Program (R03) (PA-10-011)?
PA-10-011 is an NIH discretionary funding opportunity that uses the NIH Small Research Grant (R03) mechanism to support small, focused research projects related to drug abuse and addiction treatment development. It also includes related work in HIV prevention and chronic pain treatment where those areas intersect with substance use and treatment settings.
What is the main purpose of this FOA?
The central purpose is to provide a practical funding pathway for discrete, tightly scoped studies that can be completed within a two-year period using limited resources. It is positioned as a way to move an intervention or research approach forward without the budget, infrastructure, or timeline expected of larger projects.
Who is this opportunity intended to support?
This program is intended to support early career investigators and also established investigators who are pivoting into a new research direction and need an on-ramp for a smaller, well-defined project.
What research areas and intervention types does the FOA emphasize?
The FOA targets behavioral, combined, sequential, or integrated interventions, including models that blend behavioral approaches with pharmacological components, in the context of drug abuse and addiction treatment development.
What specific topic areas are highlighted by NIH in this opportunity?
The highlighted areas include: (1) drug abuse treatment interventions across real-world settings, especially interventions tailored for patients with comorbidities; (2) prevention of HIV acquisition or transmission among individuals in drug abuse treatment; (3) improving adherence to drug abuse treatment as well as adherence to HIV medications and addiction pharmacotherapies; and (4) interventions to treat chronic pain, particularly where chronic pain intersects with substance use and treatment considerations.
Does the FOA encourage work focused on patients with comorbidities?
Yes. NIH explicitly notes interest in interventions tailored for patients who have comorbidities such as co-occurring mental health conditions, infectious diseases, or other health complications that can affect treatment response and engagement.
How does HIV prevention fit within the scope of PA-10-011?
The FOA includes a major emphasis on preventing HIV acquisition or transmission among individuals who are in drug abuse treatment, recognizing treatment settings as important points for HIV risk reduction, testing, linkage, and prevention services.
What does the FOA say about adherence-focused research?
The FOA emphasizes improving adherence both to drug abuse treatment and to related medication regimens, including HIV medications and addiction pharmacotherapies, reflecting the public health impact of sustained engagement and medication-taking behavior.
Is chronic pain research included, and how is it framed?
Yes. The FOA includes interventions to treat chronic pain, noting the intersection with substance use through issues such as opioid prescribing, misuse risk, and the need for non-addictive or integrative pain management strategies.
What kinds of projects are considered a good fit for an R03 under this FOA?
The FOA is flexible as long as the project is well-defined and feasible within two years. Examples specifically mentioned include Stage I pilot or feasibility studies, secondary analyses of existing datasets, and small self-contained research projects that do not require extensive infrastructure.
Are Stage I pilot or feasibility studies explicitly encouraged?
Yes. Stage I pilot or feasibility studies are specifically called out, including work to test acceptability, refine protocols, or generate preliminary effect size estimates.
Are secondary analyses of existing datasets allowed under this program?
Yes. The FOA explicitly lists secondary analyses of existing datasets as an example of a project type that can be a good fit for a small, focused R03 project.
Does NIH encourage work on research assessments or methodology in this FOA?
Yes. The FOA encourages projects focused on developing research assessments or methodology, such as creating or validating measures relevant to treatment outcomes, adherence, or behavioral mechanisms.
Is development of new research technology within scope?
Yes. The FOA encourages development of new research technology, including tools or platforms that improve measurement, intervention delivery, monitoring, or implementation in treatment settings.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH Small Research Grant (R03) mechanism, which is typically used for limited-scope projects and aligns with the FOA focus on modest resources and a short project period.
What is the maximum project period described for PA-10-011?
The FOA emphasizes projects that can realistically be completed within a two-year period.
How does PA-10-011 relate to PA-10-012 and PA-10-013?
PA-10-011 is described as running in parallel with other NIH announcements that share the same scientific scope but use different mechanisms: PA-10-012 uses the R01 mechanism for larger, full-scale research projects, and PA-10-013 uses the R34 mechanism, often for clinical trial planning and pilot work that precedes larger trials. Applicants are expected to choose the mechanism that matches the maturity and scale of their project.
Is there a guaranteed number of awards?
No. Awards are contingent on the availability of funds and on NIH receiving a sufficient number of meritorious applications, and no guaranteed number of awards is specified in the summary information provided.
Is cost sharing or matching required?
No. The source information states there is no cost sharing or matching requirement.
What is the CFDA number associated with this program?
The CFDA number listed is 93.279 (Drug Abuse and Addiction Research Programs).
Which agency sponsors this funding opportunity?
The sponsoring agency is the National Institutes of Health (NIH).
What types of organizations are eligible to apply?
Eligibility is broad and includes many domestic and non-domestic organization types. Examples listed include state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (including small businesses and other for-profit entities); Native American tribal governments (federally recognized) and tribal organizations; and other categories referenced in the full announcement.
Are foreign (non-U.S.) organizations eligible?
Yes. The eligibility list explicitly includes foreign (non-U.S.) organizations and other non-domestic entities.
Are minority-serving institutions and community organizations included in the eligibility list?
Yes. The eligibility list explicitly includes organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), as well as faith-based or community-based organizations.
Are U.S. territories or possessions included in eligible applicant types?
Yes. The eligibility list explicitly includes U.S. territories or possessions.
Is this FOA currently open for applications?
No. The key dates provided indicate this is a historical opportunity: the original and current closing date are both January 7, 2013, and the archive date is February 7, 2013.
When was the opportunity posted and when was it created (as listed in the source information)?
The opportunity was posted on October 14, 2009, and the creation date listed is October 28, 2010.
Where can applicants find the full announcement?
The full announcement link provided is http://grants.nih.gov/grants/guide/pa-files/PA-10-011.html
Who is listed as the contact for access or linking issues?
The contact listed for access or linking issues is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Fiscal Year (FY) 2010 Department of Defense Multidisciplinary Research Program of the University Research Initiative
Previous opportunity: High School Apprenticeship Program (HSAP)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 10 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 10 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Behavioral and Integrative Treatment Development Program (R34) Apply for PA 10 013 Funding Number: PA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 10 002 Funding Number: RFA CA 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Application and Early Stage Development of Emerging Technologies in Cancer Research (R21) Apply for RFA CA 10 003 Funding Number: RFA CA 10 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 10 005 Funding Number: RFA CA 10 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Apply for RFA CA 10 004 Funding Number: RFA CA 10 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 10 001 Funding Number: RFA CA 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01) Apply for PAR 10 018 Funding Number: PAR 10 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Drug Abuse Dissertation Research Epidemiology, Prevention, Treatment, Services, and/or Women and Sex/Gender Differences (R36) Apply for PAR 10 020 Funding Number: PAR 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| AIDS Science Track Award for Research Transition (R03) Apply for PAR 10 021 Funding Number: PAR 10 021 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| State and Community Tobacco Control Policy and Media Research (U01) Apply for RFA CA 10 008 Funding Number: RFA CA 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Effectiveness Research on Smoking Cessation in Hospitalized Patients (U01) Apply for RFA HL 10 020 Funding Number: RFA HL 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01) Apply for PA 10 025 Funding Number: PA 10 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) Apply for PA 10 026 Funding Number: PA 10 026 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award R21/R33) Apply for PAR 10 024 Funding Number: PAR 10 024 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 10 023 Funding Number: PA 10 023 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Epigenetic Approaches in Cancer Epidemiology (R01) Apply for PA 10 031 Funding Number: PA 10 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epigenetic Approaches in Cancer Epidemiology (R21) Apply for PA 10 032 Funding Number: PA 10 032 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Transdisciplinary Research in Energetics and Cancer (U54) Apply for RFA CA 10 006 Funding Number: RFA CA 10 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01) Apply for PA 10 035 Funding Number: PA 10 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Dissemination and Implementation Research in Health (R01) Apply for PAR 10 038 Funding Number: PAR 10 038 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 10 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.